Bluefruit Software vs Phillips-Medisize: full comparison for 2026
Quick verdict
Bluefruit Software (4.1/5) edges ahead of Phillips-Medisize (3.9/5) overall. Bluefruit Software is the better choice for UK device makers outsourcing firmware and testing. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Bluefruit Software vs Phillips-Medisize: head-to-head summary
| Criterion | Bluefruit Software | Phillips-Medisize |
|---|---|---|
| Founded | 2000 | 1964 |
| HQ | Redruth, Cornwall, UK | Hudson, WI, USA |
| Team size | 70–90 | ~7,000 |
| Rating | 4.1 / 5 | 3.9 / 5 |
| Primary differentiator | Small, employee-owned embedded team with medical devices as its largest market and a strong testing culture | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Time and materials, fixed project | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, Test automation | Injection molding, Automated assembly, BLE |
| Industries served | Diagnostics & lab devices, Surgical & therapeutic devices, Industrial | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Bluefruit Software vs Phillips-Medisize: overview
Bluefruit Software
Bluefruit Software has written embedded software from Redruth, Cornwall, since 2000 and is employee-owned. A Plymouth University partnership case study reports that medical devices grew from 10% to 60% of its work. It handles embedded software development, testing, some hardware development and edge AI integration, plus support for regulatory compliance and quality assurance. Its team is roughly 70 to 90 people.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Bluefruit Software vs Phillips-Medisize
| Capability | Bluefruit Software | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✗ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Bluefruit Software vs Phillips-Medisize
| Framework / platform | Bluefruit Software | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | N/A | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Bluefruit Software vs Phillips-Medisize
| Criterion | Bluefruit Software | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Bluefruit Software vs Phillips-Medisize
| Dimension | Bluefruit Software | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Diagnostics & lab devices, Surgical & therapeutic devices, Industrial | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Writing IEC 62304 firmware for a UK device startup, Independent verification of an existing device's embedded software | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Fixed project | Fixed project |
Bluefruit Software vs Phillips-Medisize: pros and cons
| Bluefruit Software | |
|---|---|
| + | Medical devices make up most of its work, so regulated firmware practice is routine |
| + | Strong emphasis on testing and test automation |
| + | Lower rates than Cambridge or London consultancies |
| + | Employee ownership |
| - | Limited hardware design compared with full product development firms |
| - | Small team; large multi-year programs may need extra partners |
| - | No industrial design, mechanical engineering or manufacturing |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Bluefruit Software?
A typical fit: writing IEC 62304 firmware for a UK device startup.
Small, employee-owned embedded team with medical devices as its largest market and a strong testing culture. Minimum engagement is not publicly disclosed. Works best with clients in Diagnostics & lab devices, Surgical & therapeutic devices, Industrial.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Bluefruit Software vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Bluefruit Software |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Bluefruit Software (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Bluefruit Software |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Bluefruit Software vs Phillips-Medisize
| Use case | Bluefruit Software fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Writing IEC 62304 firmware for a UK device startup | Strong | Limited | Bluefruit Software |
| Independent verification of an existing device's embedded software | Strong | Limited | Bluefruit Software |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Bluefruit Software vs Phillips-Medisize
Bluefruit Software (4.1/5) is the stronger overall choice for most Medical Device Development projects. Small, employee-owned embedded team with medical devices as its largest market and a strong testing culture.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Bluefruit Software vs Phillips-Medisize FAQ
Is Bluefruit Software better than Phillips-Medisize?
Bluefruit Software (4.1/5) scores higher overall, but "better" depends on your use case. Bluefruit Software's strongest advantage: medical devices make up most of its work, so regulated firmware practice is routine. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Bluefruit Software and Phillips-Medisize differ in pricing?
Bluefruit Software uses time and materials, fixed project pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Bluefruit Software or Phillips-Medisize?
Bluefruit Software is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Bluefruit Software and Phillips-Medisize?
Bluefruit Software's primary differentiator is: Small, employee-owned embedded team with medical devices as its largest market and a strong testing culture. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (70–90 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Diagnostics & lab devices, Surgical & therapeutic devices vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.